These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 16177327)
1. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites. Zhang D; Pan W Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327 [TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of a multistage combination vaccine against malaria. Zhang Q; Xue X; Qu L; Pan W Vaccine; 2007 Mar; 25(11):2112-9. PubMed ID: 17241708 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Lalitha PV; Biswas S; Pillai CR; Saxena RK Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786 [TBL] [Abstract][Full Text] [Related]
5. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820 [TBL] [Abstract][Full Text] [Related]
6. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice]. Cao Y; Zhang DM; Pan WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293 [TBL] [Abstract][Full Text] [Related]
7. High-level production and purification of P30P2MSP1(19), an important vaccine antigen for malaria, expressed in the methylotropic yeast Pichia pastoris. Brady CP; Shimp RL; Miles AP; Whitmore M; Stowers AW Protein Expr Purif; 2001 Dec; 23(3):468-75. PubMed ID: 11722185 [TBL] [Abstract][Full Text] [Related]
8. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771 [TBL] [Abstract][Full Text] [Related]
9. Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth. Bruder JT; Stefaniak ME; Patterson NB; Chen P; Konovalova S; Limbach K; Campo JJ; Ettyreddy D; Li S; Dubovsky F; Richie TL; King CR; Long CA; Doolan DL Vaccine; 2010 Apr; 28(18):3201-10. PubMed ID: 20188680 [TBL] [Abstract][Full Text] [Related]
10. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines. Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179 [TBL] [Abstract][Full Text] [Related]
12. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175. Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929 [TBL] [Abstract][Full Text] [Related]
14. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. Pan W; Huang D; Zhang Q; Qu L; Zhang D; Zhang X; Xue X; Qian F J Immunol; 2004 May; 172(10):6167-74. PubMed ID: 15128804 [TBL] [Abstract][Full Text] [Related]
16. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Yadava A; Ockenhouse CF Infect Immun; 2003 Sep; 71(9):4961-9. PubMed ID: 12933838 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates. Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134 [TBL] [Abstract][Full Text] [Related]
19. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648 [TBL] [Abstract][Full Text] [Related]
20. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes. Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]